Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Rose 20.9% in 2022

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 1.6 billion yuan in 2022, up 20.9% year-on-year.

Meanwhile, the company posted 2.8 billion yuan in revenue, down 15% year-on-year.

At the end of the reporting period, it had 6.8 billion yuan in total assets and 200.7 million yuan in total liabilities, with a liability-to-asset ratio of 3%.